What is effective in psychoanalytic psychotherapy? a historical reprise.
WHAT IS EFFECTIVE IN PSYCHOANALYTIC PSYCHOTHERAPY? A HISTORICAL REPRISE. Am J Psychoanal. 2015 Jun;75(2):126-33 Authors: Naso RC Abstract While psychoanalysis as a field has moved from the ideal of technical neutrality to a vision of the therapist as more human, real, and empathically engaged, relatively little attention has been paid to the implications of this evolution. For Freud, technical neutrality provided an important protection against bias and suggestion, one problematized by a view of the psychoanalyst's participation and influence as intrinsic to the therapeutic enterprise. The impact of this change on the evaluation of mechanisms of change is contextualized and discussed by the author. PMID: 26177753 [PubMed - in process]
We are a society that likes results fast. We went from drive-thru lanes at fast-food restaurants to having Uber Eats bring our meal to us. Now, we can pull into a parking spot at the grocery store and have people bring our groceries right out to our car at the designated time. Or we can just have our groceries brought right to our house. Two-day shipping has become the norm and we can obtain entire degrees online without having to inconvenience ourselves with going to class. There’s no denying, we like things done fast. But, when it comes to mental health, recovery is a journey, not a sprint. It’s fu...
ConclusionsThe majority of ATPDs are not detected/treated by EIS or CHR-P services, receive heterogeneous treatments and short-term clinical follow-up. ATPDs have a high risk of developing severe clinical outcomes beyond persistent psychotic disorders and unmet clinical needs that are not targeted by current mental health services.
Authors: Purgato M, Jayaram G, Surkan PJ, Bass J, Bolton P PMID: 30642409 [PubMed - as supplied by publisher]
Authors: Cuijpers P, Karyotaki E, Reijnders M, Ebert DD PMID: 30642408 [PubMed - as supplied by publisher]
ConclusionsFrom an interpersonal perspective, the relationship between the diagnostic groups is well described by the severity continuum hypothesis, with similar interpersonal problems related to Nonassertiveness and lower levels of general interpersonal stress in the SAD group compared to the two AvPD groups. However, other differences in severity do not fit the severity continuum hypothesis, as there are no differences in severity on the global severity index, and, moreover, the SAD group has the most severe problems on the SCL ‐90 phobic anxiety scale. Interpersonal pathoplasticity is not found in the diagnostic group...
Authors: Wiborg JF, Joksimovic L Abstract According to available studies, migrant patients are more often affected by diabetes mellitus and comorbid psychological complaints than patients without a history of migration. Less is known about whether these patients receive psychotherapeutic assistance for their complaints and which factors may influence the utilisation of psychotherapy in this patient group. We sought to answer these questions by using culture sensitive material which included a screening for depressive symptoms (the Patient Health Questionnaire) and sociodemographic items. The material was completed ...
DISCUSSION: The results of the 12-WD-Scale show that psychosomatic patients appreciate wisdom attitudes and that this is associated with better coping in life. Wisdom competencies are an interesting field in psychotherapy when patients are burdened by difficult situations in life. The 12-WD-scale can provide helpful information in this regard. PMID: 30641595 [PubMed - as supplied by publisher]
Condition: Psychotherapy Interventions: Behavioral: MAC-cbt group treatment for adult ADHD; Behavioral: Jacobson Sponsors: Peter Tonn; Universitätsklinikum Hamburg-Eppendorf Not yet recruiting
CONCLUSIONS: The study confirmed the reliability and validity of the Swedish versions of PDSS and PDSS-SR. Both versions were highly sensitive to the effects of two PD-focused treatments and can be used both in clinical and research settings. However, further investigation of the factor structures of both the PDSS and PDSS-SR is warranted. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01606592. PMID: 30636466 [PubMed - as supplied by publisher]